Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1991 3
1992 2
1993 1
1994 2
1995 1
1996 4
1997 7
1998 4
1999 3
2000 6
2001 6
2002 6
2003 2
2004 2
2005 1
2006 6
2007 11
2008 3
2009 6
2010 10
2011 13
2012 6
2013 6
2014 6
2015 11
2016 14
2017 7
2018 8
2019 12
2020 14
2021 15
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
The Rise of Non-Tuberculosis Mycobacterial Lung Disease.
Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, Bell SC, Thomson RM, Miles JJ. Ratnatunga CN, et al. Among authors: doolan dl. Front Immunol. 2020 Mar 3;11:303. doi: 10.3389/fimmu.2020.00303. eCollection 2020. Front Immunol. 2020. PMID: 32194556 Free PMC article. Review.
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype.
Habel JR, Nguyen THO, van de Sandt CE, Juno JA, Chaurasia P, Wragg K, Koutsakos M, Hensen L, Jia X, Chua B, Zhang W, Tan HX, Flanagan KL, Doolan DL, Torresi J, Chen W, Wakim LM, Cheng AC, Doherty PC, Petersen J, Rossjohn J, Wheatley AK, Kent SJ, Rowntree LC, Kedzierska K. Habel JR, et al. Among authors: doolan dl. Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24384-24391. doi: 10.1073/pnas.2015486117. Epub 2020 Sep 10. Proc Natl Acad Sci U S A. 2020. PMID: 32913053 Free PMC article.
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
Nguyen THO, Rowntree LC, Petersen J, Chua BY, Hensen L, Kedzierski L, van de Sandt CE, Chaurasia P, Tan HX, Habel JR, Zhang W, Allen LF, Earnest L, Mak KY, Juno JA, Wragg K, Mordant FL, Amanat F, Krammer F, Mifsud NA, Doolan DL, Flanagan KL, Sonda S, Kaur J, Wakim LM, Westall GP, James F, Mouhtouris E, Gordon CL, Holmes NE, Smibert OC, Trubiano JA, Cheng AC, Harcourt P, Clifton P, Crawford JC, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Torresi J, Kedzierska K. Nguyen THO, et al. Among authors: doolan dl. Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15. Immunity. 2021. PMID: 33951417 Free PMC article.
Plasmodium immunomics.
Doolan DL. Doolan DL. Int J Parasitol. 2011 Jan;41(1):3-20. doi: 10.1016/j.ijpara.2010.08.002. Epub 2010 Sep 16. Int J Parasitol. 2011. PMID: 20816843 Free PMC article. Review.
ISV Congress back to Europe.
Doolan DL, Lu S. Doolan DL, et al. Hum Vaccin Immunother. 2018;14(9):2101-2104. doi: 10.1080/21645515.2018.1518065. Hum Vaccin Immunother. 2018. PMID: 30285587 Free PMC article. No abstract available.
Defining the targets of antiparasitic compounds.
Skinner-Adams TS, Sumanadasa SD, Fisher GM, Davis RA, Doolan DL, Andrews KT. Skinner-Adams TS, et al. Among authors: doolan dl. Drug Discov Today. 2016 May;21(5):725-39. doi: 10.1016/j.drudis.2016.01.002. Epub 2016 Jan 16. Drug Discov Today. 2016. PMID: 26784142 Review.
Acquired immunity to malaria.
Doolan DL, Dobaño C, Baird JK. Doolan DL, et al. Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents. doi: 10.1128/CMR.00025-08. Clin Microbiol Rev. 2009. PMID: 19136431 Free PMC article. Review.
Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response.
Doolan DL, Kozlakidis Z, Zhang Z, Paessler S, Su L, Yokota YT, Shioda T, Rodriguez-Palacios A, Kaynar AM, Ahmed R, Samy A, Bradby H, Kalergis AM, Dutta MJ, Kogut M, Zhang SY. Doolan DL, et al. Front Public Health. 2021 Nov 30;9:807159. doi: 10.3389/fpubh.2021.807159. eCollection 2021. Front Public Health. 2021. PMID: 34917586 Free PMC article. No abstract available.
182 results